| P50 | author | David I Bernstein | Q107723691 |
| | Eduardo L. Franco | Q39669535 |
| | Jessica Kahn | Q59827135 |
| P2093 | author name string | Lili Ding | |
| | Darron R Brown | |
| | Lea E Widdice | |
| | Lisa Higgins | |
| | Aaron C Ermel | |
| P2860 | cites work | Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study | Q28245583 |
| | Prevalence of human papillomavirus infection in young women receiving the first quadrivalent vaccine dose | Q33701106 |
| | Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students | Q33963919 |
| | Concurrence of multiple human papillomavirus infections in a large US population-based cohort | Q34553582 |
| | The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study | Q34705454 |
| | Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction | Q36128894 |
| | Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009-2013. | Q36418117 |
| | Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes | Q37288157 |
| | Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study | Q37836160 |
| | Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014. | Q38974297 |
| | Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials | Q38993490 |
| | Human Papillomavirus Prevalence in Unvaccinated Heterosexual Men After a National Female Vaccination Program | Q39213761 |
| | Change in Human Papillomavirus Prevalence Among U.S. Women Aged 18-59 Years, 2009-2014. | Q40060651 |
| | Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community | Q40509494 |
| | An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies | Q41962966 |
| | Factors Associated With HPV Vaccine Initiation, Vaccine Completion, and Accuracy of Self-Reported Vaccination Status Among 13- to 26-Year-Old Men. | Q42362015 |
| | Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33. | Q44038372 |
| | Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women | Q45713389 |
| | Differences between vaccinated and unvaccinated women explain increase in non-vaccine-type human papillomavirus in unvaccinated women after vaccine introduction | Q47422435 |
| | Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females - Post-hoc analysis of a community-randomized clinical trial (II). | Q47548387 |
| | Acquisition, Persistence, and Clearance of Human Papillomavirus Infection among Male Virgins Residing in Brazil, Mexico, and the United States | Q47574048 |
| | Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. | Q47921143 |
| | Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy | Q49165143 |
| | Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination | Q50098691 |
| | The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. | Q51490108 |
| | Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. | Q54710732 |
| | Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction | Q90642299 |
| | Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction | Q91001532 |
| | Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women | Q91167741 |
| | Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices | Q95784494 |
| P433 | issue | 45 | |
| P304 | page(s) | 6832-6841 | |
| P577 | publication date | 2019-09-30 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction | |
| P478 | volume | 37 | |